Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

Sevinc A., ÖZKAN M., Ozet A., DANE F., Oksuzoglu B., Isikdogan A., ...Daha Fazla

ONCOTARGETS AND THERAPY, cilt.11, ss.419-426, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11
  • Basım Tarihi: 2018
  • Doi Numarası: 10.2147/ott.s106342
  • Dergi Adı: ONCOTARGETS AND THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.419-426
  • Anahtar Kelimeler: chemotherapy, febrile neutropenia, neutrophil, ANC recovery, supportive care, myelosuppressive, COLONY-STIMULATING FACTOR, NON-HODGKINS-LYMPHOMA, FEBRILE NEUTROPENIA, G-CSF, RECEIVING CHEMOTHERAPY, CANCER-CHEMOTHERAPY, BREAST-CANCER, LUNG-CANCER, RISK, CHOP
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background: We studied the comparative effectiveness of biosimilar filgrastim vs original filgrastim in patients with chemotherapy-induced neutropenia.